Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2

被引:6
|
作者
Goh, Gerard Kian-Meng [6 ]
Dunker, A. Keith [1 ]
Foster, James A. [2 ,3 ]
Uversky, Vladimir N. [4 ,5 ]
机构
[1] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[2] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA
[3] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA
[4] Univ S Florida, Morsani Coll Med, USF Hlth Byrd Alzheimers Res Inst, Dept Mol Med, Tampa, FL 33620 USA
[5] Russian Acad Sci, Fed Res Ctr, Inst Biol Instrumentat, Lab New Methods Biol,Pushchino Sci Ctr Biol Res, Pushchino 142290, Russia
[6] Gohs BioComp, Singapore 548957, Singapore
关键词
pangolin; intrinsic; disorder; protein; nucleocapsid; virulence; shell; COVID; coronavirus; vaccine; immune; antibody; nucleoprotein; membrane; matrix; attenuate; severe acute respiratory; omicron; MOLECULAR RECOGNITION FEATURES; INTRINSIC DISORDER; PROTEINS; NUCLEOPROTEIN; VIRULENCE; BINDING; VIRUS; ROLES; MORFS;
D O I
10.1021/acs.jproteome.2c00001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The shell disorder models have predicted that SARS-CoV-2 is of a specific but peculiarevolutionary nature. All coronaviruses (CoVs) closely related to SARS-CoV-2 have been found to have thehardest outer shells (M protein) among CoVs. This hard shell (low M percentage of intrinsic disorder(PID)) is associated with burrowing animals, for example, pangolins, and is believed to be responsible forthe high contagiousness of SARS-CoV-2 because it will be more resistant to antimicrobial enzymes found insaliva/mucus. Incoming clinical and experimental data do support this along with a prediction based onanother aspect of the shell (N, inner shell) disorder models that SARS-CoV-1 is more virulent than SARS-CoV-2 because SARS-CoV-2 produces fewer virus copies in vital organs even if large amounts of infectionsparticles are shed orally and nasally. A phylogenetic study using M reveals a closer relationship of SARS-CoV to pangolin-CoVs than the bat-RaTG13 found in Yunnan, China. Previous studies may have beenconfused by recombinations that were poorly handled. The shell disorder models suggest that a pangolin-CoV strain may have entered the human population in 2017 or before as an attenuated virus, which couldexplain why SARS-CoV is found to be highly adapted to humans
引用
收藏
页码:874 / 890
页数:17
相关论文
共 50 条
  • [21] Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients
    George, Santosh
    Pal, Anasuya Chattopadhyay
    Gagnon, Jacqueline
    Timalsina, Sushma
    Singh, Pallavi
    Vydyam, Pratap
    Munshi, Muhammad
    Chiu, Joy E.
    Renard, Isaline
    Harden, Christina A.
    Ott, Isabel M.
    Watkins, Anne E.
    Vogels, Chantal B. F.
    Lu, Peiwen
    Tokuyama, Maria
    Venkataraman, Arvind
    Casanovas-Massana, Arnau
    Wyllie, Anne L.
    Rao, Veena
    Campbell, Melissa
    Farhadian, Shelli F.
    Grubaugh, Nathan D.
    Dela Cruz, Charles S.
    Ko, Albert, I
    Perez, Amalia Z. Berna
    Akaho, Elikplim H.
    Moledina, Dennis G.
    Testani, Jeffrey
    John, Audrey R.
    Ledizet, Michel
    Ben Mamoun, Choukri
    KIDNEY360, 2021, 2 (06): : 924 - 936
  • [22] SARS-CoV-2 (COVID-19) and cystic fibrosis
    Stanton, Bruce A.
    Hampton, Thomas H.
    Ashare, Alix
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (03) : L408 - L415
  • [23] Adaptive immunity to SARS-CoV-2 and COVID-19
    Sette, Alessandro
    Crotty, Shane
    CELL, 2021, 184 (04) : 861 - 880
  • [24] SARS-CoV-2: Remarks on the COVID-19 Pandemic
    Egbert Piasecki
    Archivum Immunologiae et Therapiae Experimentalis, 2020, 68
  • [25] COVID-19: implications of SARS-CoV-2 in Colombia
    Almeida-Espinosa, Alexander
    Sarmiento-Ardila, Jorge A.
    GACETA MEDICA DE MEXICO, 2020, 156 (04): : 334 - 338
  • [26] The evolution of SARS-CoV-2 and the COVID-19 pandemic
    Si, Yuanfang
    Wu, Weidong
    Xue, Xia
    Sun, Xiangdong
    Qin, Yaping
    Li, Ya
    Qiu, Chunjing
    Li, Yingying
    Zhuo, Ziran
    Mi, Yang
    Zheng, Pengyuan
    PEERJ, 2023, 11
  • [27] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515
  • [28] SARS-CoV-2: The Monster Causes COVID-19
    Song, Chang
    Li, Zesong
    Li, Chen
    Huang, Meiying
    Liu, Jianhong
    Fang, Qiuping
    Cao, Zitong
    Zhang, Lin
    Gao, Pengbo
    Nie, Wendi
    Luo, Xueyao
    Kang, Jianhao
    Xie, Shimin
    Lyu, Jianxin
    Zhu, Xiao
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [29] SARS-CoV-2 reinfection and COVID-19 severity
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Hoang, Van Thuan
    Delerce, Jeremy
    Delorme, Lea
    Colson, Philippe
    Brouqui, Philippe
    Fournier, Pierre-Edouard
    Raoult, Didier
    Gautret, Philippe
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 894 - 901
  • [30] SARS-CoV-2/COVID-19: a primer for cardiologists
    A. A. F. de Vries
    Netherlands Heart Journal, 2020, 28 : 366 - 383